secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001628280-24-035600
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners Q2 revenue up 15% to $379.2M; net loss widens to $28.8M
--------------------------------------------------------------------------

- Total revenue $379.2M (+15% YoY); capitated revenue $374.3M (+15% YoY).
- Gross profit $14.0M (down from $26.8M); medical margin $41.1M (down from $50.5M).
- Net loss $28.8M (vs $27.6M); Adjusted EBITDA loss $8.8M (vs +$0.2M).
- FY2024 guidance: revenue $1.45-$1.55B; medical margin $230-$250M; Adjusted EBITDA $20-$40M.
- CEO cites top-line growth and balance sheet improvement from capital raise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024035600/0001628280-24-035600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024035600/piii-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-035600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer